INCOME TAXES (Tables)
   | 
12 Months Ended | 
Dec. 31, 2023  | 
| INCOME TAXES | 
 
 | 
| Schedule of component of net loss | 
   | 
   | 
Years Ended December 31,  | 
   | 
 
   | 
   | 
2023  | 
   | 
   | 
2022  | 
   | 
 
Domestic  | 
   | 
$ | 
(7,777,184  | 
) | 
   | 
$ | 
(8,745,293  | 
) | 
 
(Loss) before provision for income taxes  | 
   | 
   | 
(7,777,184  | 
) | 
   | 
   | 
(8,745,293  | 
) | 
 
 
 | 
| Schedule Of The Company's tax expense differs from the "statutory" tax expense | 
   | 
   | 
For the Years Ended December 31,  | 
   | 
 
   | 
   | 
2023  | 
   | 
   | 
2022  | 
   | 
 
Income tax (benefit) / Expense at federal statutory rate  | 
   | 
$ | 
(1,633,209  | 
) | 
   | 
   | 
21.0 | 
% | 
   | 
$ | 
(1,836,512  | 
) | 
   | 
   | 
21.0 | 
% | 
 
Apportioned state income taxes  | 
   | 
   | 
(95,082  | 
) | 
   | 
   | 
1.2 | 
% | 
   | 
   | 
(131,407 | 
) | 
   | 
   | 
1.5 | 
% | 
 
Stock based compensation  | 
   | 
   | 
89,502 | 
   | 
   | 
   | 
(1.2  | 
)% | 
   | 
   | 
297,653 | 
   | 
   | 
   | 
(3.3 | 
)% | 
 
Rate change  | 
   | 
   | 
46,848 | 
   | 
   | 
   | 
(0.6  | 
)% | 
   | 
   | 
(31,180  | 
) | 
   | 
   | 
0.3 | 
% | 
 
Return to provision adjustments  | 
   | 
   | 
5,968 | 
   | 
   | 
   | 
(0.1  | 
)% | 
   | 
   | 
(1,515 | 
) | 
   | 
   | 
0.0 | 
% | 
 
Other non-deductible items  | 
   | 
   | 
1,195 | 
   | 
   | 
   | 
0.0 | 
% | 
   | 
   | 
- | 
   | 
   | 
   | 
0.0 | 
% | 
 
Change in valuation allowance  | 
   | 
   | 
1,584,778 | 
   | 
   | 
   | 
(20.3  | 
)% | 
   | 
   | 
1,702,961 | 
   | 
   | 
   | 
(19.5  | 
)% | 
 
Total income tax provision  | 
   | 
$ | 
- | 
   | 
   | 
   | 
0.0 | 
% | 
   | 
$ | 
- | 
   | 
   | 
   | 
0.0 | 
% | 
 
 
 | 
| Schedule Of Deferred Tax Assets And Liabilities | 
   | 
   | 
 For the Years Ended  
December 31, 
 | 
   | 
 
   | 
   | 
2023  | 
   | 
   | 
2022  | 
   | 
 
Deferred tax assets/(liabilities)  | 
   | 
   | 
   | 
   | 
   | 
   | 
 
Federal net operating loss carryforwards  | 
   | 
$ | 
8,703,105 | 
   | 
   | 
$ | 
7,606,833 | 
   | 
 
State net operating loss carryforwards  | 
   | 
   | 
130,413 | 
   | 
   | 
   | 
74,353 | 
   | 
 
Stock based compensation  | 
   | 
   | 
2,665,017 | 
   | 
   | 
   | 
2,738,159 | 
   | 
 
Section 174 research and experimental expenditures  | 
   | 
   | 
623,902 | 
   | 
   | 
   | 
374,926 | 
   | 
 
Accrued compensation  | 
   | 
   | 
254,637 | 
   | 
   | 
   | 
- | 
   | 
 
Operating leases  | 
   | 
   | 
1,973 | 
   | 
   | 
   | 
- | 
   | 
 
Total deferred tax assets  | 
   | 
   | 
 12,379,047  | 
   | 
   | 
   | 
 10,794,271  | 
   | 
 
Other deferred tax liabilities  | 
   | 
   | 
(178  | 
) | 
   | 
   | 
(180 | 
) | 
 
Total deferred tax assets (liabilities)  | 
   | 
$ | 
12,378,869 | 
   | 
   | 
$ | 
10,794,091 | 
   | 
 
Valuation allowance  | 
   | 
   | 
(12,378,869  | 
) | 
   | 
   | 
(10,794,091 | 
) | 
 
Total deferred income taxes  | 
   | 
$ | 
- | 
   | 
   | 
$ | 
- | 
   | 
 
 
 | 
| Summary Of Operating Loss Carryforwards | 
   | 
   | 
 Net Operating Losses recorded as Federal 
deferred tax asset 
 | 
   | 
   | 
 Net Operating Losses recorded as State 
deferred tax asset 
 | 
   | 
 
Total expiring operating losses (incurred prior to December 31, 2017)  | 
   | 
   | 
- | 
   | 
   | 
   | 
- | 
   | 
 
Non-expiring operating losses (incurred after December 31, 2017)  | 
   | 
   | 
41,443,359 | 
   | 
   | 
   | 
2,371,136 | 
   | 
 
Total Operating Loss  | 
   | 
$ | 
41,443,359 | 
   | 
   | 
$ | 
2,371,136 | 
   | 
 
 
 |